Stockholders of Ivax Corp., a holding company withsubsidiaries involved in pharmaceuticals, medical diagnosticsand specialty chemicals, have approved a 3-for-2 stock split,payable on or about Nov. 15 to shareholders of record as of Oct.28.
The Miami company also said Monday that stockholdersapproved an increase in the number of shares issuable underthe Ivax stock option plan from 50 million shares to 250million shares.
The stock (NASDAQ:IVX) closed Monday at $39.63, up $2.75.
(c) 1997 American Health Consultants. All rights reserved.